The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
170 jobs Number of planned job creations
Announcement Date
13 October 2010
Employment effect (start)
Foreseen end date
Description
Pharmaceutical manufacturer Pfizer announced its intention to invest €61 million in its sites in Puurs and Zaventem (Flanders). This investment will result in the creation of 170 new jobs. Some 100 jobs will be created in the Puurs branch with a view to launching a production line focusing on making new complex types of syringes. Another 70 jobs for senior researchers will be created at the site in Zavantem which will host the veterinary medicine activities being moved there from Sandwich (UK).
Sources
14 October 2010: Le Soir
13 October 2010: Trends/tendance
Citation
Eurofound (2010), Pfizer, Business expansion in Belgium, factsheet number 71064, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/71064.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
